Feds probe FedEx, UPS for online pharmacy ties; BMS employee murdered at HIV conference;

@FiercePharma: Pfizer CEO Ian Read ordered to testify in Chantix case. More | Follow @FiercePharma

> About 40 Catalent employees are being let go at a facility in U.K. as the company adjusts its workforce. Story

> FedEx and UPS both acknowledged that they are under federal investigation for their parts in delivering drugs ordered from online pharmacies. Story

> Drugmakers are rethinking how many business events they intend to attend. Item

> Sanofi ($SNY) will take trials to sites in Asia to test its new drug for dengue fever, a disease that affects up to 100 million each year. Report

> Elaborate packaging may actually hurt the shot that some drugs have in the market. Blog post

Biotech News

 @FierceBiotech: From FierceBiotechIT.com: Cmed expanding in North Carolina as CRO-tech combos take off. Story | Follow @FierceBiotech

 @JohnCFierce: SR One, etc., provide $37.5M round for Applied Genetic Technologies. Working on gene therapies. News | Follow @JohnCFierce

 @RyanMFierce: Cmed expanding in North Carolina as CRO-tech combos take off. Report | Follow @RyanMFierce

> Troubled sequencing pioneer Helicos shelters in bankruptcy court. Story

> Road kill or takeover target? Amarin in limbo as it waits for key FDA decision. Report

> Booming Novo Nordisk shoots for top drugmaker status. Item

Medical Device News

 @FierceMedDev: Wright Medical plans to merge with BioMimetic in a $380M deal: orthopedics + regenerative medicine = the future. More | Follow @FierceMedDev

 @MarkHFierce: St. Jude gained a CE mark for its new transcatheter aortic heart valve/transfemoral delivery system. Watch out, Sapien? News | Follow @MarkHFierce

 @DamianFierce: Big week for CRO Chiromics, signing deals with GSK and Bristol-Myers. Story | Follow @DamianFierce

> GE Healthcare slashes jobs in Vermont. Item

> Wright to grab BioMimetic in $190 million-plus agreement. Story

> HeartSine hit with Class I over defibrillator recall. News

> St. Jude Medical wins CE mark for TAVI tech. Article

Biotech IT News

> Merck backs Remedy Informatics with $6M investment. Report

> Roche engages patient groups in social media effort. Article

> Cmed expanding in North Carolina as CRO-tech combos take off. News

> Johnson & Johnson, Merck and Eli Lilly to rip red tape from clinical trials. Story

CRO News

> PPD gets high-tech for adaptive trials. Item

> Big Pharma supergroup plots clinical trial site database. Story

> Chiromics inks discovery deals with Bristol-Myers, GSK. Article

> Aptuit extends GSK partnership at Italian site. More

> WuXi ticks up income after strong Q3. Report

And Finally... A security guard in Scotland has been charged with the murder of a 42-year-old Bristol-Myers Squibb ($BMY) manager who was attending a meeting on HIV. Story

Suggested Articles

The triple combo era in cystic fibrosis is here thanks to Vertex' new OK. Five months ahead of schedule, the FDA green-lighted Trikafta Monday.

On the heels of settling bellwether cases for $45 million, Teva is offering $250 million cash and $23 billion in drugs to end all its opioid lawsuits.

Under assault in the anti-inflammatory market, J&J has focused on expanding Stelara beyond dermatology—and it just took a big step in that direction.